It has been more than a decade since the first observational study on the clinical use of cytomegalovirus (CMV) cell-mediated immunity (CMI) was published in AJT. Since then, the promise… Click to show full abstract
It has been more than a decade since the first observational study on the clinical use of cytomegalovirus (CMV) cell-mediated immunity (CMI) was published in AJT. Since then, the promise of CMI has been consistent - high CMI results predict protection against CMV outcomes and low CMI increases the likelihood of CMV outcomes.
               
Click one of the above tabs to view related content.